To effectively address critical questions related to the adoption and deployment of in silico methods for specific topics, the Avicenna Alliance has established dedicated Task Forces, composed of experts from various fields, ensuring a multidisciplinary approach to solving complex issues.
These groups collaborate to achieve concrete progress for matters as diverse as In silico AI, Patient involvement, Horizon Europe Projects, Pharmaceutical strategy, In silico oncology, Notified Bodies and Standard Organizations, etc.
By leveraging diverse expertise and fostering strong industry-academia relationships – each Task Force is led by 2 co-chairs one from academia and one from industry - the Task Forces aim to pave the way for widespread implementation and acceptance of in silico practices, ultimately benefiting patients and advancing scientific progress.
NEWS
News
BSI Joins the Avicenna Alliance to Advance Trust in In Silico Medicine
The Avicenna Alliance is delighted to welcome the British Standards Institution (BSI) – …
News
Avicenna Alliance Welcomes SILICA to Advance the Future of Artificial Data and In Silico Medicine
The Avicenna Alliance is pleased to welcome SILICA Alliance as a new partner, strengthening a shared vision to advance innovative, data-driven approaches to healthcare and medical research.
News
Avicenna Alliance Welcomes Matthieu Chareyre as APAC Task Force Co-Chair
The Avicenna Alliance is delighted to welcome Matthieu Chareyre as Co-Chair of its APAC Task …